Gene · 2523
Papers1,735
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,735
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hepatocyte-Derived Apoptotic Bodies as Pathological Intercellular Messengers in the Liver. | Biomolecules | 2026 | 41750269 | PubTator, text mining | PubMed |
| Catastrophic acute haemolytic reaction: The discovery of first Bombay phenotype in Iraq /case report. | Transfus Apher Sci | 2026 | 41747665 | PubTator, text mining | PubMed |
| Decoding Leukemic Stem Cells in AML: From Identification to Targeted Eradication. | Diseases | 2026 | 41745087 | PubTator, text mining | PubMed |
| Complex HBB gene editing outcomes revealed by a fluorescent reporter cell model. | Mol Ther Nucleic Acids | 2026 | 41736887 | PubTator, text mining | PubMed |
| Identification and validation of paraptosis-related prognostic biomarkers in lung adenocarcinoma: An observational study based on transcriptomics and clinical outcomes. | Medicine (Baltimore) | 2026 | 41731832 | PubTator, text mining | PubMed |
| Elevated endocytic trafficking mediated by GPRASP2 maintains HSC fidelity. | bioRxiv | 2026 | 41726907 | PubTator, text mining | PubMed |
| Modeling mitochondrial inheritance enables high-precision single-cell lineage tracing in humans. | bioRxiv | 2026 | 41726901 | PubTator, text mining | PubMed |
| REST-driven upregulation of SFXN3 promotes AML progression via Wnt/β-catenin activation and confers decitabine resistance. | Transl Oncol | 2026 | 41720050 | PubTator, text mining | PubMed |
| Hydrothermal approach to Co-Ni Layered Double hydroxide: high-performance electrode materials for energy storage devices. | iScience | 2026 | 41717019 | PubTator, text mining | PubMed |
| The dual role of autophagy in cartilage degradation: from mechanisms to targeted therapeutics. | Front Cell Dev Biol | 2026 | 41716288 | PubTator, text mining | PubMed |
| Extracellular vesicle microRNAs from human bone marrow MSCs suppress fibrogenesis of hepatic stellate cells by downregulation of RhoA signaling. | Stem Cells | 2026 | 41703655 | PubTator, text mining | PubMed |
| Single-cell multiomic atlas of healthy pediatric bone marrow reveals age-dependent differences in lineage differentiation driven by stromal signaling. | Nat Immunol | 2026 | 41703319 | PubTator, text mining | PubMed |
| Optimal Assessment of Vestibular Function for Predicting Clinical Outcomes in Patients Diagnosed with Sudden Deafness. | J Otolaryngol Head Neck Surg | 2026 | 41700433 | PubTator, text mining | PubMed |
| Study on the damage mechanism of deep ingate lining structure disturbed by cyclic blasting. | Sci Rep | 2026 | 41667764 | PubTator, text mining | PubMed |
| RNAseq-based meta-analyses revealed tumor suppressor-inducer fusion events in liver, oral, and ovarian cancer in the Indian population: a cancer cell surviving mechanism. | Nucleosides Nucleotides Nucleic Acids | 2026 | 41661231 | PubTator, text mining | PubMed |
| Targeted Delivery of Nucleic Acid and Protein Cargos into Primary Human Hematopoietic Stem Cells Using Bacteriophage T4. | bioRxiv | 2026 | 41659505 | PubTator, text mining | PubMed |
| Design, synthesis, and anti-liver fibrosis activity of novel non-steroidal vitamin D receptor agonists based on phenyl-indole scaffold. | Eur J Med Chem | 2026 | 41638010 | PubTator, text mining | PubMed |
| Fucosylation enhances CD34⁺ hematopoietic stem cell homing and longevity via E-selectin-mediated adhesion and signaling. | BMC Cancer | 2026 | 41612247 | PubTator, text mining | PubMed |
| Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications. | Biomark Res | 2026 | 41593811 | PubTator, text mining | PubMed |
| Acetyl-CoA acyltransferase 2 palmitoylation drives liver fibrosis by inducing hepatic stellate cell ferroptosis. | Redox Biol | 2026 | 41564793 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2523/papers?page=3